Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call on CAP-1002 Transcript
Good day, and welcome to the key opinion leader call on cardiac complications of DMD hosted by Capricor Therapeutics. I will now turn the call over to AJ Bergmann, CFO of Capricor Therapeutics. Please go ahead, Mr. Bergmann.
Before we start, I would like to (technical difficulty) making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates, our future research and development plans, including the anticipated conduct and timing of preclinical and clinical studies, our plans that are reported (technical difficulty) [additional our] plans regarding regulatory filings, potential regulatory developments involving product candidates and (technical difficulty) [uses] of existing cash and investment resources.
These forward-looking statements are based on current information, assumptions and expectations that are subject to change (technical difficulty) involve a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |